Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 14, 2015 - Issue 8
Submit an article Journal homepage
15,297
Views
45
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

Vortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder

Mayce Al-SukhniGeneral Psychiatry and Acute Care Units, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON M5T 1R8, Canada
, BScPhm PharmD (Clinical Pharmacist) ,
Nadia A MaruschakUniversity of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada
, HBSc (Research Assistant) &
Roger S McIntyreUniversity of Toronto, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada+1 416 603 5279; +1 416 603 5368; [email protected];Head, University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada
, MD FRCPC (Professor of Psychiatry and Pharmacology)
Pages 1291-1304 | Published online: 28 May 2015

Citations (45)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cheuk Ngen Chin, Azhar Zain, Solaphat Hemrungrojn, Eng Khean Ung, Patanon Kwansanit, Koon Choong Au Yong, Marvin Swee Woon Chong, Chalowat Inpa, Teck Hoe Yen, Boon Beng David Yeoh, Liam Kai Tay, Carmina Bernardo, Lionel Chee-Chong Lim, Chin Hong Yap, Calvin Fones, Ashwini Nayak & Lars Nelleman. (2018) Results of a real-world study on vortioxetine in patients with major depressive disorder in South East Asia (REVIDA). Current Medical Research and Opinion 34:11, pages 1975-1984.
Read now
Laura Orsolini, Carmine Tomasetti, Alessandro Valchera, Felice Iasevoli, Elisabetta Filomena Buonaguro, Federica Vellante, Michele Fornaro, Annastasia Fiengo, Monica Mazza, Roberta Vecchiotti, Giampaolo Perna, Andrea de Bartolomeis, Giovanni Martinotti, Massimo Di Giannantonio & Domenico De Berardis. (2016) New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine. Expert Review of Neurotherapeutics 16:5, pages 483-495.
Read now

Articles from other publishers (43)

Katherine Williams. (2023) Perimenopausal depression: review of recent findings and implications for future research. Current Opinion in Obstetrics & Gynecology 35:2, pages 150-153.
Crossref
Kyeong Ju Lee & Yu Jeung Lee. (2023) Adherence to Antidepressants in Korean Elderly Patients with Major Depressive Disorder. Korean Journal of Clinical Pharmacy 33:1, pages 62-69.
Crossref
Aleksandr M. Reznik, Timur S. Syunyakov, Aleksandr V. Mudrak, Nikolay B. Zakharov, Zhanna B. Popova, Anastasia N. Khoroshilova, Ilona G. Khurbatova, Alina M. Saifulina, Anton M. Eliseenko, Tatiana K. Matvievskaya & Angelina N. Khannanova. (2023) Treatment of Depression with Vortioxetine and Second Generation Antipsychotics During the Period of Remission Formation in Schizophrenia (Interim Data Analysis). Consortium Psychiatricum 4:1, pages 18-36.
Crossref
I-Chen Huang, Tsui-San Chang, Chiehfeng Chen & Jia-Ying Sung. (2022) Effect of Vortioxetine on Cognitive Impairment in Patients With Major Depressive Disorder: A Systematic Review and Meta-analysis of Randomized Controlled Trials. International Journal of Neuropsychopharmacology 25:12, pages 969-978.
Crossref
Susana Barbosa-Méndez, Gilberto Perez-Sánchez & Alberto Salazar-Juárez. (2022) Vortioxetine treatment decreases cocaine-induced locomotor sensitization in rats. Physiology & Behavior 257, pages 113989.
Crossref
Paula Alina Fotache, Liliana Mititelu-Tartau, Maria Bogdan, Beatrice Rozalina Buca, Liliana Lacramioara Pavel, Ana-Maria Pelin, Andreea-Daniela Meca, Cosmin-Gabriel Tartau & Gratiela Eliza Popa. (2022) Magnesium Potentiates the Vortioxetine’s Effects on Physical Performances and Biological Changes in Exercise-Induced Stress in Rats. Medicina 58:10, pages 1363.
Crossref
Nina K. Popova, Anton S. Tsybko & Vladimir S. Naumenko. (2022) The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference. International Journal of Molecular Sciences 23:15, pages 8814.
Crossref
Charles M Lepkowsky. (2022) Donepezil and α‐synuclein Constipation: A 60 Month Follow-Up. POJ Clinical Case Reports, pages 1-8.
Crossref
HuiMin Huang, PeiFen Zhang, LingLing Wu, JianBo Lai & ShaoHua Hu. (2022) Gastrointestinal Hemorrhage After Antidepressant Drug Use. Journal of Clinical Psychopharmacology 42:3, pages 333-335.
Crossref
Lucy Kate Ladefoged, Rebekka Koch, Philip C. Biggin & Birgit Schiøtt. (2022) Binding and Activation of Serotonergic G-Protein Coupled Receptors by the Multimodal Antidepressant Vortioxetine. ACS Chemical Neuroscience 13:8, pages 1129-1142.
Crossref
Gerd Laux. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1417 1424 .
Eva Kitzlerová. (2021) Depression in patients with cardiovascular disease - can be treated safely?. Medicína pro praxi 18:5, pages 316-321.
Crossref
Bernhard T. Baune, Emma Sampson, Jennie Louise, Hikaru Hori, K. Oliver Schubert, Scott R. Clark, Natalie T. Mills & Célia Fourrier. (2021) No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial. European Neuropsychopharmacology 53, pages 34-46.
Crossref
Mansi Vora. (2020) Efficacy and Tolerability of Vortioxetine in Patients with Major Depressive Disorder: A Clinical Perspective from 33 Indian Cases. Indian Journal of Private Psychiatry 14:2, pages 57-61.
Crossref
Natalie T Mills, Emma Sampson, Célia Fourrier & Bernhard T Baune. (2021) Clinical Switching Strategies of Various Antidepressants to Vortioxetine in the PREDDICT Trial. International Journal of Neuropsychopharmacology 24:4, pages 314-321.
Crossref
Cristina Segura-Garcia, Marianna Rania, Elvira Anna Carbone, Renato de Filippis, Matteo Aloi, Mariarita Caroleo, Gloria Grasso, Giuseppina Calabrò, Gilda Fazia, Filippo Antonio Staltari, Antonella Falvo, Valentina Pugliese, Raffaele Gaetano, Luca SteardoJr.Jr. & Pasquale De Fazio. (2021) Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression. Frontiers in Psychiatry 12.
Crossref
Charles M. Lepkowsky. (2021) Donepezil and α-synuclein Constipation: A 48 Month Follow-Up. POJ Clinical Case Reports, pages 1-7.
Crossref
Gerd Laux. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 8 .
Maurizio S. Riga, Connie Sanchez, Pau Celada & Francesc Artigas. (2020) Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats. Neuropharmacology 178, pages 108238.
Crossref
M. Markopoulou, D. Pappas, A. Petropoulou, P. Rosis, G. Balta, T. Vlachos, A. Galanopoulos & E. Papalexi. (2020) P.329 Real world effectiveness and acceptability of vortioxetine patients with major depressive disorder in Greece. European Neuropsychopharmacology 40, pages S191-S192.
Crossref
Muriel Vicent-Gil, Beatriz Raventós, Eduardo D. Marín-Martínez, Sara González-Simarro, Anabel Martínez-Arán, Caterina del Mar Bonnin, Joan Trujols, Josefina Pérez-Blanco, Javier de Diego-Adeliño, Dolors Puigdemont, Maria Serra-Blasco, Narcís Cardoner & Maria J. Portella. (2019) Testing the efficacy of INtegral Cognitive REMediation (INCREM) in major depressive disorder: study protocol for a randomized clinical trial. BMC Psychiatry 19:1.
Crossref
Zuleide M. Ignácio, Renato S. da Silva, Marcos E. Plissari, João Quevedo & Gislaine Z. Réus. (2019) Physical Exercise and Neuroinflammation in Major Depressive Disorder. Molecular Neurobiology 56:12, pages 8323-8335.
Crossref
Charles M. Lepkowsky. (2019) Donepezil and α-synuclein Constipation: A 36 Month Follow-Up. POJ Clinical Case Reports, pages 1-7.
Crossref
Sofiya Hupalo, Courtney A. Bryce, Debra A. Bangasser, Craig W. Berridge, Rita J. Valentino & Stan B. Floresco. (2019) Corticotropin-Releasing Factor (CRF) circuit modulation of cognition and motivation. Neuroscience & Biobehavioral Reviews 103, pages 50-59.
Crossref
Jon E. Grant, Stephanie Valle, Elizabeth Cavic, Sarah A. Redden & Samuel R. Chamberlain. (2019) A double‐blind, placebo‐controlled study of vortioxetine in the treatment of binge‐eating disorder. International Journal of Eating Disorders 52:7, pages 786-794.
Crossref
Bahareh Peyrovian, Joshua D. Rosenblat, Zihang Pan, Michelle Iacobucci, Elisa Brietzke & Roger S. McIntyre. (2019) The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 92, pages 387-404.
Crossref
Bing Cao, Caroline Park, Mehala Subramaniapillai, Yena Lee, Michelle Iacobucci, Rodrigo B. Mansur, Hannah Zuckerman, Lee Phan & Roger S. McIntyre. (2019) The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder. Frontiers in Psychiatry 10.
Crossref
Laura Mandelli, Alessandro Serretti, Stefano Porcelli, Daniel Souery, Julien Mendlewicz, Siegfried Kasper, Stuart Montgomery & Joseph Zohar. (2018) Opinion paper: poor response to treatment of depression in people in high occupational levels. Psychological Medicine 49:1, pages 49-54.
Crossref
Daniela Felice, Jean-Philippe Guilloux, Alan Pehrson, Yan Li, Indira Mendez-David, Alain M. Gardier, Connie Sanchez & Denis J. David. (2018) Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent Mechanism. Frontiers in Pharmacology 9.
Crossref
Estela Salagre, Iria Grande, Brisa Solé, Jose Sanchez-Moreno & Eduard Vieta. (2018) Vortioxetine: A new alternative for the treatment of major depressive disorder. Revista de Psiquiatría y Salud Mental (English Edition) 11:1, pages 48-59.
Crossref
Estela Salagre, Iria Grande, Brisa Solé, Jose Sanchez-Moreno & Eduard Vieta. (2018) Vortioxetina: una nueva alternativa en el trastorno depresivo mayor. Revista de Psiquiatría y Salud Mental 11:1, pages 48-59.
Crossref
Elmira Anderzhanova, Thomas Kirmeier & Carsten T. Wotjak. (2017) Animal models in psychiatric research: The RDoC system as a new framework for endophenotype-oriented translational neuroscience. Neurobiology of Stress 7, pages 47-56.
Crossref
E. Salagre, B. Solé, Y. Tomioka, B.S. Fernandes, D. Hidalgo-Mazzei, M. Garriga, E. Jimenez, J. Sanchez-Moreno, E. Vieta & I. Grande. (2017) Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives. Journal of Affective Disorders 221, pages 205-221.
Crossref
Keith A. Wesnes, Carl Gommoll, Changzheng Chen, Angelo Sambunaris, Roger S. McIntyre & Philip D. Harvey. (2017) Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments. International Clinical Psychopharmacology 32:2, pages 72-79.
Crossref
Maurizio S. Riga, Vicent Teruel-Martí, Connie Sánchez, Pau Celada & Francesc Artigas. (2017) Subchronic vortioxetine treatment –but not escitalopram– enhances pyramidal neuron activity in the rat prefrontal cortex. Neuropharmacology 113, pages 148-155.
Crossref
Filippo Caraci, Gian Marco Leggio, Salvatore Salomone & Filippo Drago. (2017) New drugs in psychiatry: focus on new pharmacological targets. F1000Research 6, pages 397.
Crossref
Hans-Peter Volz, Siegfried Kasper & Hans-Jürgen Möller. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 795 842 .
James E. Frampton. (2016) Vortioxetine: A Review in Cognitive Dysfunction in Depression. Drugs 76:17, pages 1675-1682.
Crossref
Melvyn W. B. Zhang & Roger C. M. Ho. (2016) Controversies of the Effect of Ketamine on Cognition. Frontiers in Psychiatry 7.
Crossref
Roger S. McIntyre & Yena Lee. (2016) Cognition in major depressive disorder. Current Opinion in Psychiatry 29:1, pages 48-55.
Crossref
Mark Zimmerman, Heather L. Clark, Matthew D. Multach, Emily Walsh, Lia K. Rosenstein & Douglas Gazarian. (2016) Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling. Journal of Affective Disorders 190, pages 357-361.
Crossref
Roger S. McIntyre, Yena Lee & Rodrigo B. Mansur. (2015) Treating to target in major depressive disorder: response to remission to functional recovery. CNS Spectrums 20:S1, pages 17-31.
Crossref
H.-P. Volz, S. Kasper & H.-J. Möller. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 1 48 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.